Targeted Medical Pharma, Inc. 4
4 · Targeted Medical Pharma, Inc. · Filed Sep 20, 2013
Insider Transaction Report
Form 4
Shell William
DirectorCEO/Chief Scientific Officer10% Owner
Transactions
- Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11+5,303,795→ 5,370,054 total(indirect: By Trust) - Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11+3,422,748→ 3,422,748 total(indirect: By Trust) - Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11−99,000→ 0 total - Sale
Common Stock, $.001 par value per share
2013-09-13$0.84/sh−2,000$1,680→ 208,000 total(indirect: By Spouse) - Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11+300,000→ 720,799 total(indirect: By Trust) - Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11−584,795→ 66,259 total(indirect: By Trust) - Will/Inheritance
Common Stock, $.001 par value per share
2013-09-11−8,342,748→ 722,485 total(indirect: By Trust)
Footnotes (5)
- [F1]Common stock and warrants are held by William Shell Survivor's Trust.
- [F2]Common stock held by Elizabeth Charuvastra Exemption Trust. William E. Shell is filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust.
- [F3]Common stock held by Elizabeth Charuvastra Marital Trust
- [F4]Common stock held by Elizabeth Charuvastra & William Shell Family Trust. Includes 216,408 shares of common stock beneficially owned by family and friends of Dr. Shell over which the Elizabeth Charuvastra and William Shell Family Trust dated July 27, 2006 and Amended September 29, 2006 maintains voting and dispositive control.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.90 per share.